Table 1.
Clinical and epidemiological characteristics of the 473 COVID-19 patients in Wenzhou, China
| Early clinical symptoms | Wenzhou |
|---|---|
| n/ (%) | |
| Female sex | 222 (48.4) |
| Age, Median (range)—years | 47.6 (2–93) |
| Travel or residence history within 14 days | |
| Recently been to Wuhan | 160 (33.8) |
| Outside Wuhan or Wenzhou in China | 24 (5.1) |
| Wenzhou | 289 (61.1) |
| Contact with source of transmission within 14 days | |
| Contacted with people from Wuhan | 36 (7.6) |
| Contacted with patient | 195 (41.2) |
| Related the Yintai world trade center | 17 (3.6) |
| Undiscovered source of transmission | 61 (12.9) |
| Unknown | 164 (34.7) |
| Symptoms | |
| Asymptoms | 23 (4.9) |
| Symptoms | |
| Fever | 339 (71.7) |
| Headache | 31 (6.6) |
| Cough | 204 (43.1) |
| Sore throat | 39 (8.2) |
| Sputum production | 50 (10.6) |
| Fatigue | 57 (12.1) |
| Diarrhea or appetite loss | 15 (3.2) |
| Muscle soreness | 29 (6.1) |
| Disease severity | |
| Severe | 51 (10.8) |
| Clinical outcomes | |
| Discharge from hospital | 472 (99.8) |
| Death | 1 (0.2) |
| Time from onset to diagnosis (days) | |
| Median (range) | 6.0 (0–23) |